Please ensure Javascript is enabled for purposes of website accessibility

Why CVS Health Stock Is Jumping Today

By Keith Speights – Aug 7, 2019 at 11:47AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Better-than-expected Q2 results are making investors happy.

What happened

Shares of CVS Health (CVS 1.45%) were jumping 5.9% higher as of 11:17 a.m. EDT on Wednesday. The nice gain came after the pharmacy services and health insurance giant reported its second-quarter earnings results before the market opened.

CVS Health announced that its revenue in the second quarter soared 35.2% year over year to $63.4 billion. The company posted adjusted earnings per share (EPS) of $1.89, up 11.8% from the prior-year figure. CVS Health also raised its full-year 2019 adjusted EPS guidance to $6.89 to $7.00 from $6.75 to $6.90.

Pharmacist and smiling customer in the aisle of a CVS drugstore.

Image source: Getty Images.

So what

The main reason for the positive reaction to CVS Health's second-quarter results is that it beat expectations across the board. In May, the company projected that its Q2 adjusted EPS would come in between $1.68 and $1.72. The consensus Wall Street analysts' estimate was for Q2 revenue of $62.7 billion and adjusted EPS of $1.69.

There were several reasons for CVS Health's financial improvement. The biggest, by far, is the impact of its acquisition of Aetna late last year. Without this transaction, the company's revenue growth would have been well under 5%.

However, CVS Health received help in other areas as well. A shift in the Easter holiday from the first quarter in 2018 to the second quarter in 2019 boosted year-over-year comparisons for front-store sales. The company benefited from higher brand-name drug prices. It also reported increased pharmacy volume for its pharmacy benefits management (PBM) unit and its retail pharmacy business.

Now what

CVS Health is on track for a much better year than the company thought when it provided full-year 2019 guidance in February. Look for the Aetna integration to continue as a catalyst in the future. CVS Health expects significant synergies and hopes to introduce new product offerings that take advantage of its scope of operations as a large pharmacy retailer, PBM, and health insurer.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends CVS Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

CVS Health Corporation Stock Quote
CVS Health Corporation
CVS
$96.75 (1.45%) $1.38

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
326%
 
S&P 500 Returns
102%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/03/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.